ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,412Medicare Part D Prescriptions Filled, Including Refills

Rank: 433 out of 6645

$927K Total Retail Price of All Prescriptions

Rank: 376 out of 6645

659 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 659 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 659 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 12,213 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 511 462 1 1
LEVOTHYROXINE SODIUM 496 480 2 4
AMLODIPINE BESYLATE 474 468 3 2
LISINOPRIL 411 352 4 3
FUROSEMIDE 311 294 5 11
OMEPRAZOLE 303 254 6 6
HYDROCHLOROTHIAZIDE 301 257 7 9
METOPROLOL SUCCINATE 271 264 8 24
HYDROCODONE-ACETAMINOPHEN 256 219 S3 9 5
LOSARTAN POTASSIUM 252 233 10 12
METFORMIN HCL 236 196 11 7
DONEPEZIL HCL 229 229 12 27
ALENDRONATE SODIUM 223 211 13 14
SERTRALINE HCL 194 174 14 43
ATENOLOL 192 183 15 8
CITALOPRAM HBR 180 163 16 35
TRAMADOL HCL 174 170 17 30
METOPROLOL TARTRATE 173 159 18 13
LOVASTATIN 172 146 19 15
NAMENDA 165 165 20 41
FAMOTIDINE 139 121 21 33
ATORVASTATIN CALCIUM 134 114 22 10
GLIMEPIRIDE 131 109 23 47
TRAZODONE HCL 128 108 24 60
GABAPENTIN 128 119 24 18
POTASSIUM CHLORIDE 120 119 26 28
WARFARIN SODIUM 116 106 27 16
ZOLPIDEM TARTRATE 110 92 28 17
CLOPIDOGREL 106 106 29 36
PRAVASTATIN SODIUM 105 102 30 20
SPIRIVA 105 92 30 65
DIOVAN 100 89 32 19
MELOXICAM 100 100 32 46
NEXIUM 98 87 34 40
ZETIA 98 97 34 87
ADVAIR DISKUS 95 95 36 45
OXYBUTYNIN CHLORIDE 93 93 37 129
JANUVIA 88 84 38 38
FLUOXETINE HCL 87 73 39 63
PAROXETINE HCL 85 83 40 72
ALLOPURINOL 84 84 41 31
PROAIR HFA 82 68 42 32
PANTOPRAZOLE SODIUM 81 80 43 29
CIPROFLOXACIN HCL 77 69 44 67
ENALAPRIL MALEATE 75 75 45 75
CARVEDILOL 73 65 46 25
BENAZEPRIL HCL 73 61 46 21
TRIAMTERENE-HCTZ 72 59 48 52
TAMSULOSIN HCL 71 71 49 22
LANTUS 69 65 50 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 62 51 37
VESICARE 65 54 51 148
IBUPROFEN 65 52 51 42
PLAVIX 64 64 54 49
INSULIN SYRINGE 63 59 55 61
CARBIDOPA-LEVODOPA 62 60 56 116
ACTOS 60 54 57 71
ESTRADIOL 57 50 R 58 165
RAMIPRIL 56 56 59 118
TRIAMCINOLONE ACETONIDE 56 53 59 55
DIOVAN HCT 56 51 59 64
CYMBALTA 55 36 62 78
DIGOXIN 54 54 63 59
MIRTAZAPINE 53 52 64 70
RANITIDINE HCL 53 34 64 51
SPIRONOLACTONE 52 51 66 85
FENOFIBRATE 51 40 67 74
PREMARIN 50 50 R 68 169
PEN NEEDLE 50 41 68 159
ESCITALOPRAM OXALATE 50 46 68 86
PROPRANOLOL HCL 50 46 68 151
AMITRIPTYLINE HCL 50 36 R 68 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.